logo-loader
viewHepQuant LLC

HepQuant CEO sees 'huge, unmet need' in the liver space

HepQuant LLC CEO Greg Everson joined Proactive at the Biotech Showcase 2020 in San Francisco. HepQuant is a privately-held, early-stage medical diagnostics company who's technology, licensed from the University of Colorado Denver, assesses the liver function of patients with chronic liver disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bango PLC's Ray Anderson details expanded strategic partnership with NHN Corp

Bango PLC's (LON:BGO) Ray Anderson speaks to Proactive London's Andrew Scott after announcing they've expanded its global data partnership as well as receiving a strategic investment from NHN Corp - a South Korean big data business. NHN will invest £6.5mln into the Audiens data platform,...

13 hours, 44 minutes ago

2 min read